Neuraxis director awarded 43,930 shares at $6.28

Neuraxis, INC director Aharon Gil reported three acquisitions of Common Stock of NRXS.

Rhea-AI Filing Summary

Neuraxis, INC director Aharon Gil reported three acquisitions of Common Stock of NRXS. On 2026-08-13, he received 43,930 shares at $6.28 per share as compensation for serving as an independent director. On 2026-07-29, he and Rosalind Master Fund L.P. received 2,226 and 40,068 shares, respectively, as stock dividends on their Series B Preferred Stock, based on accrued 8.5% cumulative dividends divided by $2.38. The 40,068-share position is reported as indirect ownership through Rosalind Advisors, Inc., with beneficial ownership disclaimed except for each party’s pecuniary interest, and total indirect holdings after these transactions are 548,123 shares.

Insider Trade Summary

Grant/Award: 86,224 shares

Grant/Award 3 txns

Insider Aharon Gil

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F2	43,930	$6.28	$276K
Grant/Award	Common Stock F1	2,226	--	--
Grant/Award	Common Stock F1, F3	40,068	--	--

Holdings After Transaction: Common Stock — 80,058 shares (Direct); Common Stock — 548,123 shares (Indirect, By Rosalind Advisors, Inc., the advisor to the Rosalind Master Fund L.P.)

Footnotes (3)

1. F1. The number of shares of common stock issued as a dividend on the Series B Preferred Stock to Rosalind Master Fund L.P. and the Reporting Person were 40,068 and 2,226, respectively, and was determined by dividing the accrued and unpaid 8.5% cumulative dividends on the respective Series B Preferred Stock (from the investment date, through the applicable record or conversion date) by $2.38.
2. F2. These shares of common stock were issued to the reporting person as compensation for services as independent director of the Issuer.
3. F3. Each Reporting Persons disclaims beneficial ownership over the shares except to the extent of his or its respective pecuniary interest therein.

Key Figures

Director compensation grant: 43,930 shares Grant price per share: $6.28 per share Dividend shares to reporting person: 2,226 shares +4 more

7 metrics

Director compensation grant 43,930 shares Common Stock awarded on 2026-08-13 for services as independent director

Grant price per share $6.28 per share Value assigned to 43,930-share director compensation award on 2026-08-13

Dividend shares to reporting person 2,226 shares Common Stock dividend issued on Series B Preferred Stock to the reporting person

Dividend shares to Rosalind Master Fund L.P. 40,068 shares Common Stock dividend issued on Series B Preferred Stock to Rosalind Master Fund L.P.

Cumulative dividend rate 8.5% Accrued and unpaid cumulative dividends on Series B Preferred Stock used to calculate stock dividends

Dividend conversion divisor $2.38 Accrued cumulative dividends on Series B Preferred Stock divided by $2.38 to determine share amounts

Indirect holdings after transactions 548,123 shares Total indirect Common Stock holdings reported following the 40,068-share dividend issuance

Key Terms

Series B Preferred Stock, 8.5% cumulative dividends, pecuniary interest, indirect ownership

4 terms

Series B Preferred Stock financial

"dividend on the Series B Preferred Stock to Rosalind Master Fund L.P."

Series B preferred stock is a type of ownership share issued by a company that offers certain advantages over common stock, such as priority in receiving dividends or assets if the company is sold or liquidated. It is typically issued after an initial round of funding, making it a way for investors to support a company's growth while gaining some protections and benefits. This stock matters to investors because it often provides a more secure investment position with potential for future growth.

8.5% cumulative dividends financial

"determined by dividing the accrued and unpaid 8.5% cumulative dividends"

pecuniary interest financial

"disclaims beneficial ownership over the shares except to the extent of his or its respective pecuniary interest"

indirect ownership financial

"ownership: By Rosalind Advisors, Inc., the advisor to the Rosalind Master Fund L.P."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What transactions did NRXS director Aharon Gil report on this Form 4?

Aharon Gil reported three acquisitions of Neuraxis (NRXS) Common Stock. These include a 43,930-share stock award for board service and stock dividends of 2,226 and 40,068 shares issued on Series B Preferred Stock holdings.

How many NRXS shares did Aharon Gil receive as director compensation?

He received 43,930 shares of Neuraxis Common Stock as compensation. The shares were granted on 2026-08-13 at a stated value of $6.28 per share for his services as an independent director of the issuer.

What is the nature of the 40,068 NRXS shares related to Rosalind Master Fund L.P.?

The 40,068 shares are Common Stock issued as a dividend on Series B Preferred Stock to Rosalind Master Fund L.P. They are reported as indirectly owned through Rosalind Advisors, Inc., with beneficial ownership disclaimed except for pecuniary interest.

How were the Series B Preferred stock dividends for NRXS calculated?

The stock dividends were based on 8.5% cumulative dividends on Series B Preferred Stock. Accrued and unpaid dividends from the investment date through the relevant date were divided by $2.38 to determine the Common Stock share amounts of 2,226 and 40,068.

What are Aharon Gil’s indirect NRXS holdings after these transactions?

After the reported acquisitions, indirect holdings total 548,123 shares of Neuraxis Common Stock. These shares are held through an entity relationship noted as Rosalind Advisors, Inc., acting as advisor to Rosalind Master Fund L.P.

Were these NRXS transactions executed under a Rule 10b5-1 trading plan?

The filing indicates the Rule 10b5-1 checkbox is not marked. This means the reported acquisitions, including the stock award and dividend-related shares, were not affirmatively identified as being made pursuant to a Rule 10b5-1 trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/17/2026 - 06:23 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Aharon Gil

(Last) (First) (Middle)

15 WELLESLEY STREET WEST

SUITE 326

(Street)

TORONTO A6 M4Y 0G7

(City) (State) (Zip)

ONTARIO, CANADA

(Country)

2. Issuer Name and Ticker or Trading Symbol
Neuraxis, INC [ NRXS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/13/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/29/2026		A		2,226(1)	A	(1)	36,128	D
Common Stock	08/13/2026		A		43,930(2)	A	$6.28(2)	80,058	D
Common Stock	07/29/2026		A		40,068(1)	A	(1)	548,123	I	By Rosalind Advisors, Inc., the advisor to the Rosalind Master Fund L.P.(3)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The number of shares of common stock issued as a dividend on the Series B Preferred Stock to Rosalind Master Fund L.P. and the Reporting Person were 40,068 and 2,226, respectively, and was determined by dividing the accrued and unpaid 8.5% cumulative dividends on the respective Series B Preferred Stock (from the investment date, through the applicable record or conversion date) by $2.38.

2. These shares of common stock were issued to the reporting person as compensation for services as independent director of the Issuer.

3. Each Reporting Persons disclaims beneficial ownership over the shares except to the extent of his or its respective pecuniary interest therein.

	/s/ Gilad Aharon	08/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)